No article text was recorded for this version.
pathogen genetic diversity
Version 1 of 165 papers77 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Coping with Viral Diversity in HIV Vaccine Design
- Blog: Using ``epitomes'' to model genetic diversity: Rational design of HIV vaccine cocktails
- Blog: Diversity of Salmonella spp. serovars isolated from the intestines of water buffalo calves with gastroenteritis
- Blog: Analyses reveal a novel avirulent Streptococcus suis Serotype 2 strain that induces protective immunity against challenge with the highly virulent strains
- Blog: Analysis of viral diversity for vaccine target discovery
- Blog: Exploring the S Protein of SARS-CoV-2 to Design a Novel Multi-Epitope Vaccine against COVID-19 Based on Immunoinformatics Approaches
- Blog: Hepatitis C virus genotype and subtype distribution in Chinese chronic hepatitis C patients: nationwide spread of HCV genotypes 3 and 6
- Blog: Development and Characterization of a Recombinant galT-galU Protein for Broad-Spectrum Immunoprotection Against Porcine Contagious Pleuropneumonia
- Blog: Statistical evaluation of HIV vaccines in early clinical trials
- Blog: Dissecting the Dynamics of HIV-1 Protein Sequence Diversity
- Blog: Genomic Diversity of Torque Teno Virus in Blood Samples from Febrile Paediatric Outpatients in Tanzania: A Descriptive Cohort Study
- Blog: Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention
- Blog: Bovine Herpesvirus-4 Based Vaccine Provides Protective Immunity against Streptococcus suis Disease in a Rabbit Model
- Blog: Recombinant tandem multi-linear neutralizing epitopes of human enterovirus 71 elicited protective immunity in mice
- Blog: Next-Generation Sequencing of HIV-1 RNA Genomes: Determination of Error Rates and Minimizing Artificial Recombination
- Blog: Models of RNA virus evolution and their roles in vaccine design
- Blog: Modeling HIV quasispecies evolutionary dynamics
- Blog: Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition
- Blog: Dendritic Cell Mediated Delivery of Plasmid DNA Encoding LAMP/HIV-1 Gag Fusion Immunogen Enhances T Cell Epitope Responses in HLA DR4 Transgenic Mice
- Blog: Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies
- Blog: Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques
- Blog: Development of a cell-based high throughput assay system and IN-house image analysis software for screening of active compounds against dengue virus
- Blog: Comprehensive Sieve Analysis of Breakthrough HIV-1 Sequences in the RV144 Vaccine Efficacy Trial
- Blog: Analysis of V2 Antibody Responses Induced in Vaccinees in the ALVAC/AIDSVAX HIV-1 Vaccine Efficacy Trial
- Blog: Cross-Antigenicity between EV71 Sub-Genotypes: Implications for Vaccine Efficacy
- Blog: An Etiological Investigation of Domestic Cats with Conjunctivitis and Upper Respiratory Tract Disease in Japan.
- Blog: Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice
- Blog: Sequence Variability and Geographic Distribution of Lassa Virus, Sierra Leone
- Blog: Role of genetic heterogeneity in determining the epidemiological severity of H1N1 influenza
- Blog: The Role of Viral Population Diversity in Adaptation of Bovine Coronavirus to New Host Environments
- Blog: A New Stochastic Model for Subgenomic Hepatitis C Virus Replication Considers Drug Resistant Mutants
- Blog: V-pipe 3.0: a sustainable pipeline for within-sample viral genetic diversity estimation
- Blog: Inhibition of HBV replication by a fully humanized neutralizing antibody <i>in vivo</i> and <i>in vitro</i>
- Blog: The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development
- Blog: Transcriptome-wide Cas13 guide RNA design for model organisms and viral RNA pathogens
- Blog: Resequencing microarray probe design for typing genetically diverse viruses: human rhinoviruses and enteroviruses
- Blog: Automated annotation and validation of human respiratory virus sequences using VADR
- Blog: Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection
- Blog: aBayesQR: A Bayesian method for reconstruction of viral populations characterized by low diversity
- Blog: Metabolic Network Analysis-Based Identification of Antimicrobial Drug Targets in Category A Bioterrorism Agents
- Blog: The Quantitative Analyses for the Effects of Two Wheat Varieties With Different Resistance Levels on the Fungicide Control Efficacies to Powdery Mildew
- Blog: An algal lectin griffithsin inhibits Hantaan virus infection in vitro and in vivo
- Blog: Genetic diversity of transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 in Plasmodium vivax isolates from China
- Blog: Genome-wide analysis of a avirulent and reveal the strain induces pro-tective immunity against challenge with virulent Streptococcus suis Serotype 2
- Blog: Read length versus Depth of Coverage for Viral Quasispecies Reconstruction
- Blog: Delineating the functional activity of antibodies with cross-reactivity to SARS-CoV-2, SARS-CoV-1 and related sarbecoviruses
- Blog: Isolation and characterization of Hc-targeting chimeric heavy chain antibodies neutralizing botulinum neurotoxin type B
- Blog: Zoonotic infections by avian influenza virus: changing global epidemiology, investigation, and control
- Blog: A diverse virome in kidney transplant patients contains multiple viral subtypes with distinct polymorphisms
- Blog: Structural definition of babesial RAP-1 proteins identifies a novel protein superfamily across Apicomplexa
- Blog: Indirect ELISA developed to detect antibodies against Mycoplasma synoviae P50 protein via immunoproteomic screening
- Blog: Island Cotton Gbve1 Gene Encoding A Receptor-Like Protein Confers Resistance to Both Defoliating and Non-Defoliating Isolates of Verticillium dahliae
- Blog: Canine papillomavirus: status of diagnostic methods and vaccine innovations
- Blog: Using epitomes to model genetic diversity: Rational design of HIV vaccines
- Blog: Immunogenicity and Safety of a Chemically Synthesized Divalent Group A Streptococcal Vaccine
- Blog: P19-57 LB. Gene-based vaccination protects against mucosal infection by a heterologous highly pathogenic SIV isolate in rhesus monkeys
- Blog: Modeling Evolutionary Dynamics of HIV Infection
- Blog: Proteogenomic identification of Hepatitis B virus (HBV) genotype-specific HLA-I restricted peptides from HBV-positive patient liver tissues
- Blog: Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults
- Blog: DNA and recombinant adenovirus serotype 35 and 5 preventive HIV-1 vaccines with Env A inserts elicit cross-clade binding and V1V2 antibodies
Showing 60 of 65 papers.
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_pathogen_genetic_diversity_aa266a29,
title = {pathogen genetic diversity},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/pathogen-genetic-diversity/rdr_aa266a29ce8243819705d64fb05ab3d9},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 1, frozen text):
@misc{lacuna_pathogen_genetic_diversity_aa266a29_v1,
title = {pathogen genetic diversity},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/pathogen-genetic-diversity/rdr_aa266a29ce8243819705d64fb05ab3d9/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-19},
}